CGBIO (CEO Hyun Seung Yu), a leading company specializing in bio-regenerative medicine, announced on the 24th that it has signed an industry-academia collaboration agreement with the biomedical engineering research institute of Universitas Indonesia (UI), the country’s most prestigious national university. This agreement focuses on conducting cutting-edge research for medical device development while utilizing local resources and talent to build a sustainable medical industry ecosystem and enhance global competitiveness.
CGBIO plans to establish a sustainable cooperation model that integrates the development of medical device raw materials and commercialization by capitalizing on Indonesia’s abundant physical and human resources. Through this initiative, the company aims to contribute to the local economy and the advancement of the medical industry while laying the foundation for strengthening Indonesia’s healthcare infrastructure.
A key component of this partnership is educating local talent. CGBIO, in collaboration with Universitas Indonesia, will offer internship programs and educational courses, providing local students and professionals with opportunities to participate in research and production processes. The company is committed to equipping them with hands-on experience and advanced knowledge in medical device technologies at a global level.
Hyun Seung Yu, CEO of CGBIO, said, “After witnessing the passion and exceptional capabilities of the local researchers, I am confident that we can drive global innovation together. By leveraging Indonesia’s abundant resources and talent, we aim to cultivate cutting-edge medical technologies and professionals, ultimately securing a leading position in the global medical device market by 2030.”
Eric Aoh, Head of Indonesia Business at CGBIO, added, “This collaboration is expected to contribute not only to the development of medical devices but also to the establishment of local medical infrastructure and the development of future talent.”
Moving forward, CGBIO and Universitas Indonesia will closely collaborate on three key objectives—medical device research and development utilizing local resources, talent development, and the advancement of healthcare infrastructure—to achieve sustainable and impactful results.
▲ Hyun Seung Yu, CEO of CGBIO (left), and Eric Aoh, Head of Indonesia Business at CGBIO (center), visit the research institute of Universitas Indonesia to discuss the advanced medical device development process with research representatives.
